It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Single-cell resolution analysis of complex biological tissues is fundamental to capture cell-state heterogeneity and distinct cellular signaling patterns that remain obscured with population-based techniques. The limited amount of material encapsulated in a single cell however, raises significant technical challenges to molecular profiling. Due to extensive optimization efforts, single-cell proteomics by Mass Spectrometry (scp-MS) has emerged as a powerful tool to facilitate proteome profiling from ultra-low amounts of input, although further development is needed to realize its full potential. To this end, we carry out comprehensive analysis of orbitrap-based data-independent acquisition (DIA) for limited material proteomics. Notably, we find a fundamental difference between optimal DIA methods for high- and low-load samples. We further improve our low-input DIA method by relying on high-resolution MS1 quantification, thus enhancing sensitivity by more efficiently utilizing available mass analyzer time. With our ultra-low input tailored DIA method, we are able to accommodate long injection times and high resolution, while keeping the scan cycle time low enough to ensure robust quantification. Finally, we demonstrate the capability of our approach by profiling mouse embryonic stem cell culture conditions, showcasing heterogeneity in global proteomes and highlighting distinct differences in key metabolic enzyme expression in distinct cell subclusters.
Single-cell proteomics by Mass Spectrometry (scpMS) provides unparalleled insights into cellular mechanisms from a proteome-centric standpoint. Here, the authors leverage sensitivity-tailored data acquisition methods to profile cell state heterogeneity in cultured model systems.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Üresin, Nil 2 ; Kovacs, Gergo 1 ; Phlairaharn, Teeradon 3 ; Furtwängler, Benjamin 2
; Op De Beeck, Jeff 4 ; Skovbakke, Sarah L. 1
; Goletz, Steffen 1
; Thomsen, Simon Francis 5
; Keller, Ulrich auf dem 1 ; Natarajan, Kedar N. 1
; Porse, Bo T. 6
; Schoof, Erwin M. 1
1 Technical University of Denmark, Department of Biotechnology and Biomedicine, Lyngby, Denmark (GRID:grid.5170.3) (ISNI:0000 0001 2181 8870)
2 Technical University of Denmark, Department of Biotechnology and Biomedicine, Lyngby, Denmark (GRID:grid.5170.3) (ISNI:0000 0001 2181 8870); University of Copenhagen, The Finsen Laboratory, Rigshospitalet, Faculty of Health Sciences, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X); University of Copenhagen, Biotech Research and Innovation Centre (BRIC), Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X)
3 Technical University of Denmark, Department of Biotechnology and Biomedicine, Lyngby, Denmark (GRID:grid.5170.3) (ISNI:0000 0001 2181 8870); University of Copenhagen, The Novo Nordisk Foundation Center for Protein Research, Faculty of Health Sciences, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X); Max-Planck Institute of Biochemistry, Department of Proteomics and Signal Transduction, Martinsried, Germany (GRID:grid.418615.f) (ISNI:0000 0004 0491 845X); MaxPlanck Institute of Biochemistry, Martinsried, Germany (GRID:grid.418615.f) (ISNI:0000 0004 0491 845X)
4 Thermo Fisher Scientific, Gent, Belgium (GRID:grid.5254.6)
5 University of Copenhagen, Department of Dermatology, Bispebjerg Hospital and Department of Biomedical Sciences, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X)
6 University of Copenhagen, The Finsen Laboratory, Rigshospitalet, Faculty of Health Sciences, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X); University of Copenhagen, Biotech Research and Innovation Centre (BRIC), Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X); University of Copenhagen, Dept of Clinical Medicine, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X)




